Propanc Biopharma to acquire undervalued digital asset treasury firms.

Propanc Biopharma is exploring the acquisition of Digital Asset Treasury (DAT) companies trading below their market capitalization to net asset value. The DATs hold substantial reserves of Bitcoin and Ethereum. Propanc believes this move will strengthen its balance sheet, diversify its assets, and create long-term shareholder value. The total value held by Bitcoin Treasury companies is approximately $76.9 billion, while Ethereum-based DATs collectively hold around $5.3 billion.